Monthwise SARS CoV-2 mutation statistics
| Position | Mutation | Clade |
|---|---|---|
| 212 | nsp12:L212F; | CL-3e; |
| 212 | nsp12:L212I; | CL-3e; |
| 241 | nsp12:L241-; | CL-3e; |
| 247 | nsp12:L247-; | CL-3f; |
| 247 | nsp12:L247M; | CL-3e; |
| 261 | nsp12:L261-; | CL-1a_3d;CL-3d;CL-3e; |
| 261 | nsp12:L261C; | CL-1a_3d;CL-3b;CL-3c;CL-3d;CL-3e; |
| 270 | nsp12:L270M; | CL-3b; |
| 271 | nsp12:L271-; | CL-3f; |
| 282 | nsp12:L282-; | CL-1a;CL-1b; |
| 282 | nsp12:L282I; | CL-3b; |
| 302 | nsp12:L302F; | CL-3b;CL-3e; |
| 302 | nsp12:L302M; | CL-3e; |
| 302 | nsp12:L302S; | CL-3e; |
| 308 | nsp12:L308M; | CL-3c;CL-3d; |
| 316 | nsp12:L316-; | CL-3b; |
| 329 | nsp12:L329I; | CL-3b;CL-3c;CL-3d;CL-3e; |
| 351 | nsp12:L351-; | CL-1b;CL-3e; |
| 372 | nsp12:L372-; | CL-3b;CL-3e; |
| 372 | nsp12:L372F; | CL-3b;CL-3c;CL-3d;CL-5; |
| 372 | nsp12:L372V; | CL-3f; |
| 387 | nsp12:L387P; | CL-3e; |
| 389 | nsp12:L389-; | CL-1b;CL-2;CL-3e;CL-3f;CL-5; |
| 401 | nsp12:L401-; | CL-3e; |
| 401 | nsp12:L401F; | CL-3f; |
| 498 | nsp12:L498-; | CL-3c; |
| 49 | nsp12:L49I; | CL-3d;CL-3f; |
| 514 | nsp12:L514-; | CL-3b;CL-3e;CL-3f; |
| 527 | nsp12:L527F; | CL-3e; |
| 544 | nsp12:L544-; | CL-3e; |
| 544 | nsp12:L544H; | CL-3d; |
| 575 | nsp12:L575-; | CL-3f; |
| 602 | nsp12:L602-; | CL-3e; |
| 614 | nsp12:L614F; | CL-3b;CL-3f; |
| 614 | nsp12:L614I; | CL-3e; |
| 630 | nsp12:L630F; | CL-3d;CL-3e; |
| 636 | nsp12:L636F; | CL-1a_3b;CL-3d;CL-3e; |
| 65 | nsp12:L65S; | CL-3b; |
| 673 | nsp12:L673-; | CL-3c; |
| 758 | nsp12:L758I; | CL-3b; |
| 805 | nsp12:L805F; | CL-3d;CL-3e;CL-3f; |
| 819 | nsp12:L819-; | CL-1b;CL-3b; |
| 829 | nsp12:L829-; | CL-3b;CL-3f; |
| 854 | nsp12:L854F; | CL-3e; |
| 854 | nsp12:L854H; | CL-3e; |
| 869 | nsp12:L869F; | CL-1a_3e;CL-3b;CL-3d;CL-3e;CL-3f;CL-5; |
| 883 | nsp12:L883-; | CL-3b; |
| 883 | nsp12:L883F; | CL-1a; |
| 883 | nsp12:L883M; | CL-3b; |
| 885 | nsp12:L885-; | CL-1b; |
Page 164 of 409
Tutorial Link
For More Web Development Tutorials Visit: AllPHPTricks.com